**Background:** Adipose tissue contains white adipocytes that store triglycerides and beige/brown adipocytes that express uncoupling protein 1 (UCP1) to dissipate energy as heat. Increasing beige adipocyte density is associated with elevated energy expenditure and resistance to obesity and type 2 diabetes. Naringenin (NR), a citrus polyphenol, activates PPARα and PPARγ and has been shown to upregulate UCP1 and oxygen consumption in human adipocytes. Carotenoids like β-carotene (BC) are metabolized into retinoid ligands for retinoic-X-receptors (RXRs), which heterodimerize with PPARs. This study tested whether BC could amplify NR's effects on converting white adipocytes to a beige phenotype.
**Methods:** Human adipose-derived stem cells from overweight/obese female donors were differentiated into adipocytes and treated for seven days with 8 µM NR and/or 2 µM BC (NRBC). Gene expression was measured by qRT-PCR and whole transcriptome sequencing (RNA-seq). Protein levels were assessed by Western blotting. PPARγ immunoprecipitation was used to detect RXR isoform binding. Lipolysis was measured by glycerol release after 4-hour exposure to receptor agonists (PTH, isoproterenol, dobutamine, ANP, and others). Statistical analysis used linear mixed effect models with significance at p < 0.05.
**Key Results:** BC and lutein (pro-vitamin A carotenoids) synergistically boosted UCP1 mRNA with NR (p < 0.001), while lycopene (non-pro-vitamin A) did not. NRBC synergistically increased mRNA for UCP1 (p < 0.005), GLUT4 (p < 0.02), ATGL (p < 0.04), and adiponectin (p < 0.05) compared to NR or BC alone. Protein levels of PPARα, PPARγ, PGC-1α, and NAMPT increased 3- to 6-fold (p < 0.001) without corresponding mRNA increases, suggesting post-translational stabilization. RNA-seq identified 3881 differentially expressed genes (adjusted p < 0.05). NRBC induced non-UCP1 thermogenic pathways: PM20D1 (15.7-fold), creatine kinases CKMT1A (5.1-fold), CKMT1B (3.9-fold), CKMT2 (3.8-fold), and triglyceride cycling genes (PDK4 4.2-fold, GK 2.4-fold, PCK1 3.8-fold). RXRγ was induced 10-fold. Eight receptors were significantly upregulated (Padj < 0.002), including β1AR, PTHR, TGR5, TRPM8, ADORA1, NPR1, GPER1, and GHR. PTH-stimulated lipolysis was the highest among all agonists tested and increased significantly in NRBC-treated cells (p ≤ 0.02). Isoproterenol and dobutamine-stimulated lipolysis were also significantly elevated. RXRγ was detected in PPARγ immunoprecipitates from both untreated and NRBC-treated cells, indicating constitutive binding.
**Clinical Implications:** NRBC reprograms human white adipocytes toward a beige phenotype by upregulating multiple thermogenic pathways (UCP1, creatine cycling, PM20D1/NAA uncoupling, triglyceride cycling), beneficial secreted factors (adiponectin, ANGPTL4, FNDC4, GDF11), and receptors for exercise- and cold-related hormones (β1AR, PTHR, NPR1). The increased lipolytic capacity and receptor sensitivity suggest NRBC could enhance energy expenditure in response to physiological stimuli. NR and BC have established safety profiles in humans, and this peripherally-acting combination avoids CNS side effects common to many obesity drugs. A randomized, double-blind placebo-controlled clinical trial is needed to determine whether these in vitro effects translate to weight loss and improved insulin sensitivity in humans.